🇺🇸 FDA
Pipeline program

MgSO4 plus Ropivacaine

USM/JEPeM/KK/23110854

Approved small_molecule completed

Quick answer

MgSO4 plus Ropivacaine for Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials